Effects of cardiopulmonary bypass on propofol pharmacokinetics and bispectral index during coronary surgery

• Autor(a) principal: Barbosa, Ricardo Antonio G.
• Data de Publicação: 2009
• Outros Autores: Santos, Silvia Regina C. Jorge, White, Paul F., Pereira, Valéria A., Silva Filho, Carlos R., Malbouisson, Luiz M. S., Carmona, Maria José C.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Clinics
• Texto Completo: https://www.revistas.usp.br/clinics/article/view/17997
• topic: Propofol; Target controlled infusion; Pharmacokinetics; Pharmacodynamics; Coronary surgery; Cardiopulmonary bypass

PURPOSE: Cardiopulmonary bypass is known to alter propofol pharmacokinetics in patients undergoing cardiac surgery. However, few studies have evaluated the impact of these alterations on postoperative pharmacodynamics. This study was designed to test the hypothesis that changes in propofol pharmacokinetics increase hypnotic effects after cardiopulmonary bypass. METHODS: Twenty patients scheduled for on-pump coronary artery bypass graft (group, n=10) or off-pump coronary artery bypass graft (group, n=10) coronary artery bypass grafts were anesthetized with sufentanil and a propofol target controlled infusion (2.0 µg/mL). Depth of hypnosis was monitored using the bispectral index. Blood samples were collected from the induction of anesthesia up to 12 hours after the end of propofol infusion, at predetermined intervals. Plasma propofol concentrations were measured using high-performance liquid chromatography, followed by a non-compartmental propofol pharmacokinetic analysis. Data were analyzed using ANOVA, considering p